KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Shares Outstanding (2016 - 2025)

Medpace Holdings' Shares Outstanding history spans 11 years, with the latest figure at $28.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding fell 7.38% year-over-year to $28.4 million; the TTM value through Dec 2025 reached $28.4 million, down 7.38%, while the annual FY2025 figure was $28.4 million, 7.38% down from the prior year.
  • Shares Outstanding reached $28.4 million in Q4 2025 per MEDP's latest filing, up from $28.2 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $36.0 million in Q4 2021 to a low of $28.1 million in Q2 2025.
  • Average Shares Outstanding over 5 years is $31.6 million, with a median of $31.0 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding: dropped 13.65% in 2022, then increased 1.44% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $36.0 million in 2021, then decreased by 13.65% to $31.1 million in 2022, then decreased by 1.09% to $30.8 million in 2023, then dropped by 0.4% to $30.6 million in 2024, then decreased by 7.38% to $28.4 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Shares Outstanding are $28.4 million (Q4 2025), $28.2 million (Q3 2025), and $28.1 million (Q2 2025).